Literature DB >> 10571019

Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism.

N Taniguchi1, E Miyoshi, J H Ko, Y Ikeda, Y Ihara.   

Abstract

N-acetylglucosaminyltransferases III (GnT-III) and V (GnT-V) play a pivotal role in the processing of N-linked glycoproteins, and are highly involved in cancer progression and metastasis. Expression of GnT-III and GnT-V in the liver is enhanced during hepatocarcinogenesis, although they are not expressed in the normal liver. Gene expression of GnT-V is regulated by a transcriptional factor, ets-1, which is involved in angiogenesis and invasion of tumor cells. When the formation of the product of GnT-V, GlcNAc-beta1-6 branches, is inhibited by overexpression of GnT-III, lung metastasis of melanoma cells is suppressed. Modification of glycoprotein receptors such as the receptors for epidermal growth factor and nerve growth factor by GnT-III sense transfection changes an intracellular signaling pathway, which may lead to a variety of biological alterations in tumor cells. In this review, we focus on cancer progression and metastasis in relation to GnT-III and GnT-V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571019     DOI: 10.1016/s0925-4439(99)00066-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Authors:  Haijun Zhang; Fanyan Meng; Sherwin Wu; Bas Kreike; Seema Sethi; Wei Chen; Fred R Miller; Guojun Wu
Journal:  Cancer Res       Date:  2011-07-12       Impact factor: 12.701

3.  Down regulation of N-acetylglucosaminyltransferase V facilitates all-transretinoic acid to induce apoptosis of human hepatocarcinoma cells.

Authors:  Peng Guo; Hai-jiao Chen; Qiu-yan Wang; Hui-Li Chen
Journal:  Mol Cell Biochem       Date:  2006-01-13       Impact factor: 3.396

4.  Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.

Authors:  Chang-hong Yi; Can-ping Ruan; Hao Wang; Xin-yun Xu; Yun-peng Zhao; Meng Fang; Jun Ji; Xing Gu; Chun-fang Gao
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 5.  Glycoprotein disease markers and single protein-omics.

Authors:  Kevin Chandler; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-11       Impact factor: 5.911

Review 6.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

7.  Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.

Authors:  Kenichiro Onuki; Hiroaki Sugiyama; Kazunori Ishige; Toru Kawamoto; Takehiro Ota; Shunichi Ariizumi; Masayuki Yamato; Shinichi Kadota; Kaoru Takeuchi; Akiko Ishikawa; Masafumi Onodera; Kojiro Onizawa; Masakazu Yamamoto; Eiji Miyoshi; Junichi Shoda
Journal:  J Gastroenterol       Date:  2013-04-17       Impact factor: 7.527

8.  Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.

Authors:  Hiroshi Hotta; Kazunori Hamamura; Kyoko Yamashita; Hidenobu Shibuya; Noriyo Tokuda; Noboru Hashimoto; Keiko Furukawa; Noriyuki Yamamoto; Hisashi Hattori; Shinya Toyokuni; Minoru Ueda; Koichi Furukawa
Journal:  Glycoconj J       Date:  2012-12-15       Impact factor: 2.916

9.  N-acetylglucosaminyltransferase V modifies TrKA protein, regulates the receptor function.

Authors:  Xiaoyun Yang; Jing Li; Meiyu Geng
Journal:  Cell Mol Neurobiol       Date:  2008-03-15       Impact factor: 5.046

10.  Involvement of aberrant glycosylation in thyroid cancer.

Authors:  Eiji Miyoshi; Yasuhiro Ito; Yoko Miyoshi
Journal:  J Oncol       Date:  2010-06-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.